The use of corticosteroids and corticosteroid phobia in atopic dermatitis (Q35143058)

6 August 2017

1 reference

title

The use of corticosteroids and corticosteroid phobia in atopic dermatitis (English)

1 reference

6 August 2017

Carolyn Charman

1

1 reference

6 August 2017

Hywel Williams

series ordinal

2

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

published in

Clinics in Dermatology

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

193-200

1 reference

Topical glucocorticoids with improved benefit/risk ratio: Do they exist?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Topical corticosteroid phobia in patients with atopic eczema

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Topical corticosteroids: clinical pharmacology and therapeutic use

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Counci

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Systematic review of treatments for atopic eczema.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Influence of corticosteroids on chemotactic response and collagen metabolism of human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Pharmacology and Toxicology of Infant Skin

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Percutaneous absorption of topically applied triamcinolone in children

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Study of the Effects of Hydrocortisone and Hydrocortisone 17-Butyrate Ointments on Plasma ACTH Levels and Synacthen Responses in Children with Eczema

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Adrenal function following topical steroid treatment in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Cushing Syndrome From Percutaneous Absorption of Triamcinolone Cream

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Adult height in patients with childhood onset atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Avascular necrosis of the hips following longterm use of clobetasol propionate

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Current management and therapy of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Is steroid tachyphylaxis preventable?

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Extensive visual loss with topical facial steroids

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Glaucoma following the application of corticosteroid to the skin of the eyelids

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Adverse external ocular effects of topical ophthalmic medications

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Do topical steroids reduce relapses in adults with atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

A comparison of single and multiple applications of halcinonide cream

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Frequency of application of topical corticosteroids: an overview

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Concern about the current clinical practice of diluting topical glucocorticosteroid preparations

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Managing adults with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

1 reference

7 January 2021

Why do patients with atopic dermatitis refuse to apply topical corticosteroids?

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

The finger‐tip unit—a new practical measure

1 reference

https://api.crossref.org/works/10.1016/S0738-081X(02)00368-1

7 January 2021

10.1016/S0738-081X(02)00368-1

Identifiers

DOI

1 reference

6 August 2017

1 reference